Schering-Plough To Bring Tablet-Based Allergy Vaccine To U.S. Market
This article was originally published in The Pink Sheet Daily
Executive Summary
Company signs deal with Dutch firm ALK-Abello to develop and commercialize the vaccine, marketed as Grazax in Europe.